Sana Biotechnology, Inc. (SANA)
NASDAQ: SANA · Real-Time Price · USD
3.010
-0.050 (-1.63%)
At close: Feb 21, 2025, 4:00 PM
2.990
-0.020 (-0.66%)
After-hours: Feb 21, 2025, 6:41 PM EST
Sana Biotechnology Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
328
Market Cap
672.04M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SANA News
- 6 weeks ago - Top 2 Health Care Stocks That Are Ticking Portfolio Bombs - Benzinga
- 6 weeks ago - Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Sana Biotechnology: Stock Price Rise Deserved Post Diabetes Cell Therapy Success - Seeking Alpha
- 6 weeks ago - Sana Biotechnology Stock Surges Over 200% On Wednesday - Here's Why - Benzinga
- 6 weeks ago - This Biotech Stock Just Soared 240%. Why It Can Go Higher. - Barrons
- 6 weeks ago - Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression - GlobeNewsWire
- 2 months ago - Sana: Major Inflection Point For SC291 In 2025 Targeting Lupus - Seeking Alpha
- 3 months ago - Sana Biotechnology to Present at December 2024 Investor Conferences - GlobeNewsWire